CheckMyRecalls

AvKARE recalls Irbesartan Tablets USP

Published
19 Feb 2025
Units affected
341 cartons
Agency
FDA
Country
United States

The hazard

Out of Specification for Dissolution

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Irbesartan Tablets USP, 300 mg, 50 Tablets (5 x 10) Unit Dose per carton, Manufactured for: AvKARE, Pulaski, TN 38478. NDC 50268-442-15

Brand / company
AvKARE
Codes / lots
Lot 45279, Exp 03/31/2025
Distribution
Nationwide in the USA
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 19 Feb 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.